FDA Drug Shortages
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Midazolam Injection
Status: Currently in Shortage
»Date first posted:
04/02/2020
»Therapeutic Categories: Anesthesia; Neurology
Akorn Pharmaceuticals (Revised 10/22/2021)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 10 ML Vial - Pack of 10 (NDC 17478-0524-10) | Available |
Fresenius Kabi USA, LLC (Revised 05/04/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 10 mL vial, 10 count (NDC 63323-0411-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 1 mg/mL, 2 mL prefilled syringe, 24 count (NDC 76045-0001-20) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 1 mg/mL, 2 mL vial, 25 count (NDC 63323-0411-12) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 1 mg/mL, 5 mL vial, 25 count (NDC 63323-0411-25) | Backordered. Next release May 2022. | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 1 mL fill in 2 mL vial, 25 count (NDC 63323-0412-25) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 10 mL vial, 10 count (NDC 63323-0412-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 1 mL prefilled syringe, 24 count (NDC 76045-0002-10) | Available | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 2 mL vial, 25 count (NDC 63323-0412-02) | 7 month expiry (11/2022 expiry) dating available by request to wholesalers. | Check wholesalers for inventory | Demand increase for the drug |
| 5 mg/mL, 5 mL vial, 10 count (NDC 63323-0412-05) | Available | Check wholesalers for inventory | Demand increase for the drug |
Gland Pharma Limited (Reverified 05/06/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10) | Available | Marketing partner: Athenex Pharmaceutical Division, LLC. | Demand increase for the drug |
| 25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05) | Available | Marketing partner: Athenex Pharmaceutical Division, LLC. | Demand increase for the drug |
| 25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17) | No stock available | Marketing partner: Alvogen Inc. | Demand increase for the drug |
| 50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91) | Available | Marketing partner: Alvogen Inc. | Demand increase for the drug |
| 2 mg per 2 mL Single Dose Vial (NDC 70860-600-02) | Available | Marketing partner: Athenex Pharmaceutical Division, LLC. | Demand increase for the drug |
| 2 mg per 2 mL Single Dose Vial (NDC 47781-588-68) | Available | Marketing partner: Alvogen Inc. | Demand increase for the drug |
Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals (Reverified 04/13/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50 mg/10mL vial (NDC 23155-601-42) | Available | Other | |
| 25 mg/5mL vial (NDC 23155-601-41) | Available | Other | |
| 2 mg/2mL vial (NDC 23155-600-41) | Available; On allocation due to increased demand | Other |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 04/08/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Demand increase for the drug |
| 1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Demand increase for the drug |
| 1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Demand increase for the drug |
| 5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Demand increase for the drug |
| 5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10) | Available | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Demand increase for the drug |
Hospira, Inc. (Revised 05/10/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2 mg/2mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-17) | Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2305-05) | Limited Supply Available. Next Delivery and Estimated Recovery: May 2022 | Demand increase for the drug | |
| 5 mg/mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-01) | Available |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Other |
| 50 mg/10 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-05) | Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: August 2022 |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Demand increase for the drug |
| 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial (NDC 00409-2308-02) | Available |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Other |
| 25 mg/5 mL (5 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2596-03) | Next Delivery and Estimated Recovery: August 2022 |
Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages |
Demand increase for the drug |
| 10 mg/10 mL (1 mg/mL) Multiple Dose Glass Fliptop Vial (NDC 00409-2587-05) | Limited Supply Available. Next Delivery: May 2022; Estimated Recovery: February 2023 | Demand increase for the drug | |
| 2 mg/2 mL (1 mg/mL) CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2306-62) | Discontinued | Discontinuation of the manufacture of the drug | |
| 5 mg/mL CARPUJECT™ Luer Lock Glass Syringe (NDC 00409-2307-60) | Discontinued | Discontinuation of the manufacture of the drug |
WG Critical Care (Reverified 05/03/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 50mg/50mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag (NDC 44567-610-10) | Available | Please check wholesalers for inventory. | |
| 100mg/100mL (1mg/mL) in 0.9% Sodium Chloride single-dose bag (NDC 44567-611-10) | Available | Please check wholesalers for inventory. |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English